SOHM, Inc. takes a step forward in achieving maximum value for their organizations stakeholders with strategic rebranding and global expansion

CHINO HILLS, CA / ACCESSWIRE / November 15, 2021 / SOHM, Inc. (OTC PINK: SHMN), a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering many treatment categories, today announced the signing of an engagement agreement with Sivana Group, Inc., based in Southern California.

Mr. Baron Night, President and CEO of SOHM Inc., said: “The Sivana Group brings exceptional industry experience, strong business relationships, successful branding strategies and limitless creativity to our company and its community. wide range of products. The Sivana group will initially be responsible for developing a rebranding and expansion plan, developing product portfolios and determining a long-term growth strategy. “

Sivana Group is a Southern California-based company that helps clients meet their toughest challenges and overcome regulatory pressures with a focus on transformational change, business resilience, and technological innovation. This agreement allows the company to make further progress towards achieving its “Global Prospero” vision.

Shelley Mehta, Founder and CEO of Sivana Group, said: “Our experience is in execution and marketing strategies for companies that operate in the ‘eutics’ industry, including the pharmaceutical and cosmeceutical industry where SOHM operates ”. Mehta continued, “We are working with large companies who want to further commercialize their existing technologies and intellectual property in new markets and segments. The collaboration of our two companies creates a powerful opportunity to extend SOHM’s product line to an even wider audience in the pharmaceutical, cosmeceutical and nutraceutical industries.

About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a “Global Prosper” vision that tries to build continued growth. The manufacturing and marketing of SOHM targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as strategic alliances with manufacturing facilities in the United States. Although SOHM’s generic pharmaceuticals are exported worldwide and were introduced in the United States in early 2013, SOHM continues to focus on distribution to emerging markets in Africa, Latin America and the United States. South East Asia.
To learn more about SOHM, Inc., visit

Safe Harbor Declaration:
This press release contains “forward-looking statements”, which are statements which are not purely historical and include statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in forward-looking statements due to many factors. These factors include, among others, the inherent uncertainties associated with new projects and companies in the development phase. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update any forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be correct. Investors should consult all information contained in this document and should also refer to the risk factor disclosure described in our annual report for the most recent year, our quarterly reports uploaded from time to time on

For more information please contact:
SOHM, Inc.


See the source version on

Source link